BRITISH scientists have developed the world’s first stem cell therapy to cure the most common cause of blindness. Surgeons predict it will become a routine, one-hour procedure that will be generally available in six or seven years’ time.
The treatment involves replacing a layer of degenerated cells with new ones created from embryonic stem cells. It was pioneered by scientists and surgeons from the Institute of Ophthalmology at University College London and Moorfields eye hospital.
This week Pfizer, the world’s largest pharmaceutical research company, will announce its financial backing to bring the therapy to patients.
The treatment will tackle age-related macular degeneration (AMD), the most common cause of blindness. It affects more than 500,000 Britons and the number is forecast to increase significantly as people live longer. The disease involves the loss of eye cells.
Via The Times Online.
The only problem that I see with this procedure being done in America is that, if there is not sweeping changes done to our own healthcare system, it will be virtually unaffordable.
1 comment:
Did the government or Pfizer develop the treatment? Private companies strive for profit making products and just happen to share with the public. Socialized med did not develope the product private medical r and d did. Think about it.
Post a Comment